ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

House Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg

DOW JONES NEWSWIRES Republicans on the House Energy and Commerce Committee are seeking information from several large drug companies about their agreements with the Obama administration during the formation of the health-care reform law, Bloomberg News reported Friday, citing three people familiar with the talks. One of the people said the Republicans turned to direct negotiations with the companies after trade group Pharmaceutical Research and Manufacturers of America didn't cooperate, Bloomberg reported. The committee is seeking documents and other information from Pfizer Inc. (PFE), Merck & Co. (MRK), Amgen Inc. (AMGN), Abbott Laboratories (ABT) and AstraZeneca PLC (AZN), Bloomberg reported. Rep. Michael Burgess (R., Texas) told Bloomberg that "this has been like pulling teeth, trying to get information." A spokesman for PhRMA said "we have been cooperating with the committee on an ongoing basis since the investigation began," Bloomberg reported. Full story at http://www.bloomberg.com/news/2012-05-04/obama-deal-with-drugmakers-said-to-be-probed-by-house.html -Dow Jones Newswires; 212-416-2900

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
08/27/201520:00:00FDA Approves Amgen's Cholesterol-Lowering Drug Repatha -- Update
08/27/201519:20:00FDA Approves New Amgen Cholesterol Drug
08/27/201518:40:00FDA Approves Amgen's Repatha Cholesterol Drug
08/27/201517:50:00FDA Approves Amgen's New Cholesterol-Lowering Medication Repatha™...
08/25/201509:45:00U.S. Hot Stocks: Hot Stocks to Watch
08/25/201509:40:00Amgen Files for U.S. Approval of Therapy for Dialysis Patients
08/25/201509:32:00Amgen Files for U.S. Approval of Therapy for Dialysis Patients
08/25/201509:15:00Amgen To Present New Long-Term Repatha™ (Evolocumab) Data Analysis A...
08/25/201509:00:00Amgen Submits New Drug Application For Novel Intravenous Calcimimetic...
08/20/201517:59:39Statement of Changes in Beneficial Ownership (4)
08/18/201514:40:00Amgen Reaches $71 Million Settlement With States
08/18/201514:25:00Amgen Reaches $71 Million Settlement With States Related to Promotion...
08/18/201513:01:00Press Release: AG Jepsen: Connecticut Joins $71 Million Multistate...
08/18/201512:47:00Press Release: Amgen to Pay $71 Million for Improper Drug Marketing...
08/18/201509:00:00Amgen And University Of California, Berkeley Announce Multi-Year...
08/06/201517:22:58Amended Quarterly Report (10-q/a)
08/06/201516:49:23Statement of Changes in Beneficial Ownership (4)
08/06/201508:51:21India Shares Edge Higher
08/05/201506:17:16Quarterly Report (10-q)
08/04/201518:45:24Statement of Changes in Beneficial Ownership (4)

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad